The seven members of the NOX/DUOX family are responsible for generation of the superoxide and H 2 O 2 required for a variety of host defense and cell signaling functions in nonphagocytic cells. Two members, the dual oxidase isozymes DUOX1 and DUOX2, share a structurally unique feature: an N-terminal peroxidase-like domain. Despite sequence similarity to the mammalian peroxidases, the absence of key active site residues makes their binding of heme and their catalytic function uncertain. To explore this domain we have expressed in a baculovirus system and purified the C. elegans (CeDUOX1 ) and human (hDUOX1 ) DUOX1 "peroxidase" domains. Evaluation of these proteins demonstrated that the isolated hDUOX1 does not bind heme and has no intrinsic peroxidase activity. In contrast, CeDUOX1 1-589 binds heme covalently, exhibits a modest peroxidase activity, but does not oxidize bromide ion. Surprisingly, the heme appears to have two covalent links to the protein despite the absence of a second conserved carboxyl group in the active site. Although the N-terminal dual oxidase motif has been proposed to directly convert superoxide to H 2 O 2 , neither DUOX1 domain demonstrated significant superoxide dismutase activity. These results strengthen the in vivo conclusion that the CeDUOX1 protein supports controlled peroxidative polymerization of tyrosine residues, and indicate that the hDUOX1 protein either has a unique function or must interact with other protein factors to express its catalytic activity.
The purposeful generation of reactive oxygen species (ROS) 2 within phagocytic cells has long been recognized as a component of their antibacterial defense system (1, 2) . ROS generation is mediated by a membrane bound NADPH oxidase (NOX) and is activated by a diverse number of stimuli. The NOX enzymes catalyze the NADPH-dependent one-electron reduction of oxygen to superoxide (O 2 -) (3). It has long been debated whether the generation of similar species in other cell types is also an intentional, physiologically controlled process or is an accident of aerobic respiration. This controversy has been clarified by identification of the NOX/DUOX family of NADPH oxidases. The seven members of this family (NOX 1-5, DUOX1 and 2) have been shown to produce the ROS utilized for functions as varied as cellular signaling, host defense, and thyroid hormone biosynthesis (4) (5) (6) (7) (8) . The latter function is specifically attributed to the DUOX members of this family. DUOX1 and 2 (formerly also known as ThOX1 and 2 for thyroid oxidase) were first identified in the mammalian thyroid gland (9, 10) . This localization is not exclusive as both can also be found in non-thyroid tissues; DUOX1 is prominent in airway epithelial cells (11) and DUOX2 in the salivary glands and gastrointestinal tract (4, 12, 13) . Homologues of each DUOX have also been identified in lower organisms, including C . elegans and Drosophila melanogaster (14) . The human isoforms are 83% homologous, approximately 190 kDa in size (after glycosylation), and are located in close proximity, as they are configured head-to-head on human chromosome 15 (15, 16) . The glycosylation of both DUOX1 and 2 is extensive, contributing approximately 30 kDa to the total apparent protein mass (17) . Recent investigation has uncovered that maturation factors DUOXA1 and DUOXA2 are required to achieve heterologous expression of each DUOX in full-length, active form (18) .
Structurally, DUOX1 and 2 are characterized by a defining N-terminal, extracellular domain exhibiting considerable sequence identity with the mammalian peroxidases ("peroxidase" domain), a transmembrane (TM) segment appended to an EFhand calcium binding cytosolic region and a NOX2 homologous structure (6 TMs tethered to NADPH oxidase; Figure 1A ) (10) . Both isoforms have a conserved calcium binding site in the Nterminal "peroxidase" domain, mimicking that found in MPO, LPO, EPO, and TPO. Interestingly, while homologous to these heme-containing peroxidases, the peroxidase-like domains of the DUOX proteins lack some of the highly conserved amino acid residues that are thought to be essential for heme binding and/or peroxidase catalysis ( Figure 1B) (16) .
Functionally, mature DUOX enzymes appear to produce H 2 O 2 , in contrast to other NOX family members that produce superoxide. This activity is regulated by Ca 2+ concentration through triggered dissociation of NOXA1 and possibly other as yet unidentified interacting proteins (19) . As the Nterminal "peroxidase" domain is the structural feature that differentiates the dual oxidases from the NOX proteins, it may be directly responsible for the conversion of superoxide to H 2 O 2 . To investigate this crucial domain we report here the first expression, purification, and characterization of the H. sapiens (hDUOX1 ) and C. elegans (CeDUOX1 1-589 ) DUOX1 "peroxidase" domains. We demonstrate that heme is covalently bound to CeDUOX1 1-589 (2 covalent bonds are suggested by heme hydroxylation studies), whereas hDUOX1 does not stably bind this co-factor. Both domains share overall sequence similarity with the mammalian peroxidases (specifically LPO), but only CeDUOX1 1-589 exhibits peroxidase activity, as measured with either ABTS (2,2'-azino-bis(3-ethylbenzothiazoleline-6-sulfonic acid)) or tyrosine ethyl ester as the substrate. We also demonstrate that neither DUOX1 domain has significant superoxide dismutase or halide oxidizing activity. Figure S1 ). Spectrophotometric measurements were performed on a Cary 50 Bio UV-Vis s p e c t r o p h o t o m e t e r ( V a r i a n ) . L i q u i d chromatography-mass spectrometry (LC-MS) was performed on a Waters Micromass ZQ coupled to a Waters Alliance HPLC system (2695 separations module, Waters 2487 dual λ absorbance detector). For experiments utilizing H 2 O 2 , concentrations were determined spectrophotometrically at 240 nm by using the molar extinction coefficient ε = 43.6 M -1 cm -1 (20) . All experiments were performed at room temperature unless otherwise stated.
EXPERIMENTAL PROCEDURES

Materials and General Methods-
Plasmid Constructs-The original source of the human duox1 gene was Quick-clone cDNA from human lung (Clontech). The gene encoding the "peroxidase" domain of hDUOX1 (residues 1-593) was amplified from plasmid pETDUOXnc (Donghak Kim and Paul Ortiz de Montellano, unpublished results) using primers JLM-BacntDUOX1F and JLM-Bac-DUOX1R (see Supplemental Data, Table S1 ) with cloned Pfu polymerase (Stratagene); these primers introduced BamHI and EcoRI sites, respectively, onto the 5' and 3' ends of the duox1 open reading frame. After digestion, the PCR product was ligated into the corresponding sites of the baculovirus expression vector pAcGP67-b (BD Biosciences, pJLM04). To introduce a C-terminal 6-His tag and retain the B a mHI and EcoRI restriction sites, duox1 was amplified from pJLM04 with primers JLM-Bac-ntDUOX1F and JLMBacCDUOX-R (Table S1 ) and subcloned into TOPO vector pCR 2.1 (Invitrogen, pJLM05). This plasmid construct was subsequently digested with B a m HI and EcoRI, and the gene inserted by ligation into pAcGP67-b (pJLM08).
The original source of the C. elegans duox1 gene was a ProQuest C. elegans cDNA Library (Invitrogen). The gene encoding the "peroxidase" domain of CeDUOX1 (residues 1-589) was amplified from the cDNA library using primers JLM-BacC-Celegans1F and JLM-BacCCelegans1R that introduced BamHI and PstI sites onto the 5' and 3' ends of the duox1 open reading frame ( Table S1 ). The PCR product was subcloned into TOPO vector pCR 2.1 (Invitrogen, pJLM022). This plasmid construct was subsequently digested with BamHI and PstI, and the gene inserted by ligation into pAcGP67-b (pJLM023).
Generation of Recombinant Baculoviruses-
Plasmids pJLM08 and pJLM023 were cotransfected with viral baculogold DNA into Sf9 insect cells, according to the manufacturer's instructions (BD Biosciences). The resulting viruses were plaque assayed to generate high titer recombinant baculovirus stocks amplified (two rounds of amplification in Sf9 cells) from single viral populations. In a typical overexpression, 1 L of H5 cells (2.0 x 10 6 cells/mL) supplemented with 250 µM 5-aminolevulinic acid (Fluka) were infected with the hDUOX1 1-593 -6His viral stock at a MOI = 5 for 3 days at 27 °C. After 72 h of infection, cell suspensions were concentrated and purified by nickel affinity chromatography (nickelnitrilotriacetic acid-agarose (Ni-NTA); see supplemental data for purification details); the purified protein was stored at -20 °C. The protein stock concentration was determined by Bradford assay in triplicate (21) .
Expression and Purification of hDUOX1
Expression and Purification of CeDUOX1 1-589 -CeDUOX1 1-589 -6His was overexpressed and purified as described above for hDUOX1 1-593 -6His; the purified protein was stored at -20 °C and its concentration determined by Bradford assay.
Heme Staining Protocol-Detection of hemeprotein complexes from SDS PAGE was achieved by incubation with a solution containing tetramethylbenzidine (TMB) and addition of H 2 O 2 for color development, as previously described (22) . Experimental details are included in the supplemental data. was then consumed by incubation with catalase (5U) for 5 min. The resulting samples were chromatographed as described above, with the proportion of covalently bound heme determined by the percent of the total 400 nm integration attributed to the peak(s) that co-eluted with the 215 nm absorbing protein peak (27-30 min).
HPLC Analysis of Covalent
CeDUOX1 1-589 Dihydroxyheme (DHH)
Isolation-CeDUOX1 1-589 (2 mg/mL, 70 µL) was digested by incubation for 1 h with trypsin (1 mg/mL, 2 µL) at room temperature, followed by addition of proteinase K (Fermentas, 20 mg/mL, 3 µL); the digest was continued overnight at 37 °C. As a control, hemin was purchased from Sigma Aldrich; a stock solution was created by dissolving 1-2 mg in 200 µL 1N NaOH, followed by addition of 9.8 mL buffer (20 mM phosphate buffer, 0.4 M NaCl, pH 8.0); 2.5 µL stock was diluted into 25 µL buffer for analysis. Digested protein (40 µL) and porphyrin (25 µL) separations were achieved on a Vydac 214MS reversed phase C4 column (150 x 4.6 mm) using water containing 0.1% TFA (solvent A) and acetonitrile containing 0.09% TFA (solvent B) on an Agilent 1200 series HPLC instrument. All samples were eluted at a flow rate by guest on October 30, 2017 http://www.jbc.org/ Downloaded from of 1 mL/min, with a 3 min isocratic wash of 15% solvent B, followed by a linear gradient of 15-43% solvent B over 31 minutes, monitored at 400 nm. The same gradient and column were utilized for analysis of the observed peaks by LC-MS.
Reduction and CO Binding Studies of CeDUOX1 1-589 -The ferrous and CO bound absorbance spectra for CeDUOX1 1-589 (6 µ M ) were collected in 100 mM phosphate buffer, pH 7.0; 800 µL total sample volume. To achieve reduction, sodium dithionite (8 µL, 100 mM) was added to an argon flushed enzyme sample in a sealed cuvette. After reduction, the enzyme was incubated with CO for 30 seconds and spectra were collected until saturation was demonstrated.
Cyanide Binding to CeDUOX1 1-589 -The cyanide (CN -) bound absorbance spectrum for CeDUOX1 1-589 (6 µM) was collected via titration with KCN in 100 mM phosphate buffer, pH 7.0. A stock solution of KCN (10 mM) was utilized to titrate from 12.5 µM to 225 µM until enzyme saturation was demonstrated. A titration curve was established by plotting delta absorbance (ΔA), from subtraction of difference spectra maxima (423 nm) and minima (402 nm), against CN -concentration; a dissociation constant was determined from this plot at half the maximum ΔA observed.
ABTS activity assay comparison of the DUOX1 homologs-Peroxidase activity was measured using 500 nM ABTS incubated with 500 nM LPO, hDUOX1 or CeDUOX1 1-589 in 50 mM phosphate buffer (pH 7.0, chelexed). The reactions were initiated by the addition of H 2 O 2 (50 µ M). Each reaction was monitored by recording the absorbance intensity at 414 nm as a function of time. The molar extinction coefficient for ABTS at 414 nm is ε = 36,800 M -1 cm -1 (23).
Peroxidase Activity Assay(s) with Tyrosine Ethyl Ester-Enzyme peroxidase activity was measured using tyrosine ethyl ester as a substrate (1 mM) in PBS buffer (pH 7.4, chelexed). LPO, CeDUOX1 1-589 and hDUOX1 (1 µ M) were assayed; each reaction was initiated with the addition of H 2 O 2 (100 µ M). Initial reaction kinetics of tyrosine cross-linking were monitored using a Fluorolog 3 Spectrofluorometer (Horiba Jobin Yvon), with excitation at 295 nm and emission monitored at 414 nm using 1 nm excitation and emission slits at room temperature. After 1 h reaction time, LPO and CeDUOX1 1-589 assays were further analyzed by direct injection onto a 50 x 2.1 mm C18 reversed phase column (Waters XTerraMS) on an Agilent 1200 series HPLC instrument. The assays were characterized utilizing an isocratic gradient of 9% acetonitrile in water (0.1% FA), followed by a linear gradient of 9-10% acetonitrile in water (0.1% FA) over 10 min (0.2 mL/min) with detection at 280 nm and fluorescence detection by excitation at 295 nm and emission at 414 nm. The same gradient and column were utilized for analysis of the observed peaks by LC-MS.
Superoxide Dismutase Activity Assay(s)-
Superoxide dismutase (SOD) activity was measured by the percentage reaction inhibition rate of enzyme (SOD, hDUOX1 or CeDUOX1 1-589 ) with WST-1 substrate (a water soluble tetrazolium dye) and xanthine oxidase using a SOD Assay Kit (Fluka, 19160) according to the manufacturer's instructions. Each endpoint assay was monitored by absorbance at 450 nm (the absorbance wavelength for the colored product of WST-1 reaction with superoxide) after 20 min of reaction time at 37 °C. All enzyme stocks were made in 50 mM HEPES buffer, pH 7.0, 5% glycerol (to allow for CaCl 2 addition); each assay was performed in triplicate.
Bromide Oxidation Activity Assay(s)-MCD (1mM, 50 µL), NaBr (2M, 50 µL) and enzyme (50 nM LPO, 50 µ L; 5 µ M CeDUOX1 1-589 or hDUOX1 , 50 µ L) were mixed in a quartz cuvette. To this solution was added 850 µL of H 2 O 2 (0.52 mM in 50 mM citrate buffer, pH 4.4). The resulting solution was mixed and the absorbance at 292 nm was recorded as a function of time. The initial velocity was calculated from the change in absorbance between 10-30 s; the molar extinction coefficient of MCD at 292nm is ε = 20,000 M -1 cm -1 (24) .
RESULTS
Design and Expression of Soluble DUOX1 "Peroxidase" Domain Constructs-hDUOX1 and CeDUOX1 are large membrane bound proteins (~180 kDa) predicted to contain an extracellular N-terminal domain tethered by a transmembrane helix to a C-terminal region with 6 TM domains, two cytosolic EF hand motifs, and an NADPH oxidase domain ( Figure 1A ). This N-terminal extracellular domain is homologous to classical peroxidases such as MPO and TPO (43% sequence similarity (17)); however, neither the hDUOX1 nor CeDUOX1 "peroxidase" domains contains the full complement of heme-binding and catalytic residues, as shown in Figure 1B . This partial sequence alignment with the classical peroxidases demonstrates that both DUOX homologs lack the catalytic distal histidine residue (S108, hDUOX1; Y105, CeDUOX1) and the aspartate residue that in MPO and LPO covalently binds to the heme co-factor through an ester linkage (L107, hDUOX1; A104, CeDUOX1) (25, 26) . HDUOX1 lacks additional critical peroxidase residues: the glutamate that forms the second covalent bond to the heme (R241) and the proximal histidine residue (S331). Both of these amino acids are conserved in the CeDUOX1 homolog. Despite sequence similarity, the only critical residue of the heme binding region conserved among mammalian peroxidases and the DUOX proteins is the catalytic arginine residue (R405, hMPO; R238, hDUOX1; R235 CeDUOX1). Soluble constructs are required to elucidate the function of this region for both DUOX homologs.
Initially, the full length human and C. elegans DUOX1 proteins were truncated using the TMHMM transmembrane helix algorithm to identify the primary sequences likely to compose their entire extracellular "peroxidase" domains (27) . Based on this analysis, we designed constructs of hDUOX1 (residues 1-593) and CeDUOX1 (residues 1-589) for expression in E. coli. N-terminal and C-terminal 6His tagged and GST tagged constructs were created, but attempts at expression under various conditions did not yield soluble protein (data not shown). As a result, our expression efforts shifted to a baculovirus system. This technique often yields recombinant proteins with the proper fold, oligomerization, and post-translational modifications, thus generating a protein structurally and functionally similar to its native counterpart. Both truncated DUOX1 homologues were inserted into baculovirus expression vector pAcGP67-b, which allows for secretion of the recombinant protein (resulting in the N-terminal addition of five amino acids to the expressed protein as part of the secretion signal sequence; Supplemental Data, Figure S1 ). Nterminal and C-terminal 6His tagged constructs of the DUOX1 proteins were co-transfected with baculovirus DNA into Sf9 cells to obtain high-titer viral stocks for infection (see experimental procedures for details).
HDUOX11 -593 and CeDUOX1 1-589 were stably overexpressed (via infection of H5 cells) as Cterminal 6His tagged proteins (no protein was obtained from the N-terminally tagged constructs) and purified by Ni-NTA affinity chromatography ( Figure 2A) ; each DUOX1 protein was eluted with ~100 mM imidazole.
Yields were reproducible at levels of approximately 0.7 mg/L for both hDUOX1 and CeDUOX1 .
Visual inspection of each protein stock solution, supported by absorbance spectra ( Figure  2B ), demonstrated that heme was associated with CeDUOX1 1-589 and not with the isolated hDUOX1 . Further investigation by heme titration failed to demonstrate specific heme binding by hDUOX1 . Absorbance spectroscopy of CeDUOX1 1-589 identified a Soret maximum at 408 nm with a 408/280 nm ratio of 0.55. This Soret is significantly blue shifted from that seen for LPO, EPO or TPO (412-413 nm), which have two heme-covalent bonds, or MPO (428 nm), which has three such bonds (28) . This absorbance shift suggests that the number of covalent bonds or other structural aspects of the heme pocket are responsible for the Soret difference for CeDUOX1 . The nature of the heme co-factor interaction with CeDUOX1 1-589 was initially evaluated by TMB staining of denaturing polyacrylamide gels. Under these separating conditions, the presence of heme was confirmed by its coincident migration with the CeDUOX1 1-589 "peroxidase" domain (Figure 2A) , establishing that at least a portion of the heme cofactor is indeed covalently bound to the recombinant protein.
To examine the extent of heme attachment to CeDUOX1 1-589 , an HPLC system was utilized under acidic conditions that favor dissociation of by guest on October 30, 2017 http://www.jbc.org/ Downloaded from non-covalently bound heme from the apoprotein (29) . As shown in Figure 2C , only 60% of the prosthetic heme co-elutes with the 215 nm absorbing protein peak; this is consistent with results for LPO expressed in baculovirus (29) . Investigation of this recombinant LPO covalent heme binding has shown the process to be autocatalytic, as opposed to requiring an enzymatic system such as that required for covalent heme attachment in cytochrome c (30) (31) (32) . To determine if a similar autocatalytic process is responsible for heme oxidation and covalent incorporation in CeDUOX1 1-589 , the protein was pre-incubated with varying concentrations of H 2 O 2 , and the extent of covalent heme binding was evaluated by HPLC. Figure 2D highlights With covalent heme binding established as a major interaction between co-factor and enzyme, the nature of this linkage in CeDUOX1 1-589 was examined. Mammalian peroxidases form covalent linkages to the 1 and 5 methyl groups of the heme porphyrin through conserved aspartate and glutamate residues ( Figure 1B) . The result of enzymatic digestion and LC-MS analysis of the classic peroxidases with 2 covalent bonds (LPO, TPO, EPO) is a 1,5 dihydroxyheme derivative. Mutation studies of heme proteins (HRP F41E, HRP S73E, LPO D225E, LPO E375D) to investigate the autocatalytic nature and sequence of covalent bond formation have also led to nonnative linkages at the 3 and 8 methyl positions (33, 34) . Due to single covalent bond formation in each mutant enzyme, once digested (trypsin/pronase or proteinase K), each liberated heme co-factor was found as a monohydroxyheme (1-OH, 3-OH, 5-OH, or 8-OH) derivative. For further investigation of the nature of covalent heme binding, CeDUOX1 1-589 was digested and analyzed by HPLC and LC-MS to determine whether a monohydroxy-or dihydroxyheme derivative would result. A heme derivative was isolated (m/z 650, t = 13.2 min), and determined, both by retention time and mass, to be dihydroxyheme, suggestive of 2 covalent proteinheme linkages (Figure 3) . This covalent bond character, although consistent with that of the known mammalian peroxidases, was highly unexpected in the case of CeDUOX1 1-589 because the aspartate residue required for covalent heme binding is not conserved in this enzyme. It is clear that a different carboxyl residue, or a different amino acid altogether, is involved in formation of the second covalent bond to the heme.
Structural Stability of the DUOX1 Proteins-
Circular dichroism measurements were performed on hDUOX1 1-593 and CeDUOX1 1-589 to confirm the protein constructs are properly folded ( Figure  S2A ). The far-UV spectra (195-250 nm) for both homologs support an α-helical structure, with prominent troughs at 208 nm and ~220 nm, characteristic of LPO and other mammalian peroxidases (35) (36) (37) . For further insight into the stability of hDUOX1 and CeDUOX1 1-589 , tryptophan (Trp) fluorescence emission spectra where collected for each upon excitation at 292 nm, exhibiting broad emission bands with λ max at 341 nm and 348 nm, respectively ( Figure S2B ). Both maxima suggest a folded protein structure resulting in protection of Trp residues from solvent exposure. The DUOX1 homologs contain a large number of Trp residues (hDUOX1 1-593 : 19 Trp; CeDUOX1 1-589 : 11 Trp); both the disparity in the number of Trp residues and quenching by the heme chromophore likely contribute to the difference in emission intensity. The observed wavelength maxima shift to ~351 nm upon thermal unfolding (80 °C, Figure S2B ) and decrease in fluorescence intensity, consistent with quenching due to solvent exposure upon unfolding. Chemical denaturation of both proteins using 7 M guanidine hydrochloride resulted in a further red shift of the λ max to approximately 360 nm; this result suggests that the DUOX "peroxidase" domain(s) retain some tertiary structure upon thermal denaturation, consistent with previous studies on LPO (37) .
Small Ligand Binding to CeDUOX1 1-589 -CO and CN
-molecules bind tightly to mammalian peroxidases (38, 39) . These interactions result in steady-state spectral changes from association with the heme iron in the distal binding pocket.
To determine if the binding pocket of CeDUOX1 1-589 will allow such interactions, steady-state absorbance spectra were collected and are shown in Figure 4 . Ferric CeDUOX1 1-589 exhibits a Soret band maximum at 408 nm with bands at 533 nm and 623 nm in the visible region ( Figure 4A /B and Table S2 ). Upon reduction with sodium dithionite, CeDUOX1 1-589 undergoes a red shift to 425 nm, with Q band maxima at 533 nm and 557 nm. Exposure of the reduced protein to CO leads to the formation of a complex with the ferrous heme iron, demonstrated by a blue shift of the Soret band to 419 nm, with Q bands at 539 nm and 563 nm.
Cyanide adduct formation, in contrast to CO, results in a stable complex with the ferric heme iron. Consistent with other mammalian peroxidases, upon formation of the Fe +3 -CN -adduct, the Soret band of CeDUOX1 1-589 exhibited a red shift ( Figure 4C ). In the case of LPO (consistent with the other classical mammalian peroxidases, Table S2 ), upon complexation with CN -, the Soret maxima experiences a large shift of 20 nm, from 412 nm to 432 nm; CeDUOX1 1-589 exhibits a smaller shift of 7 nm to a Soret maxima of 415 nm at saturation (40) . The reduced magnitude of the shift may be related to a difference in the properties of the heme binding pocket and/or the presence of a tyrosyl residue in place of the distal histidine. The hydrogen bonding interactions of the ligated cyanide are likely to differ significantly with a distal tyrosine rather than an imidazole residue. To further characterize the cyanide binding event, a titration was used to monitor the UV-vis spectral shift upon the addition of potassium cyanide (12.5 µM to 225 µ M) to 6 µM CeDUOX1 . This study established a dissociation constant for cyanide binding of 25 µM; this value is consistent with dissociation constants found for mammalian peroxidases LPO (42 µM) and TPO (10 µM) at neutral pH (39, 41) .
Activity Studies for the DUOX "Peroxidase" Domain(s)-Due to the absence of several residues that are conserved in peroxidases, including the distal histidine residue, the actual catalytic function of the hDUOX1 and CeDUOX1 "peroxidase" domains remains uncertain. It has been shown through site-specific mutagenesis that the distal catalytic histidine in peroxidases is crucial to their activity. When mutated in such enzymes as horseradish peroxidase (HRP), cytochrome c peroxidase, and dehaloperoxidase, a significant loss of activity is observed (42) (43) (44) (45) (46) . This fact has led researchers to postulate that the N-terminal region of DUOX1 may not act as a classical peroxidase, but rather as a SOD (8, 12) . In an effort to clarify the function of these domains, now available as purified and structurally sound proteins, we examined each homolog with regard to its peroxidase and SOD activity.
Catalytic activity studies were first conducted with ABTS, a substrate commonly used to evaluate peroxidase activity. In contrast to a standard peroxidase, LPO ((3.3 ± 1.0) x 10 3 mol oxidized per min/mol of enzyme, hDUOX1 exhibited no peroxidase activity, whereas CeDUOX1 1-589 had a modest activity of 14.1 ± 0.8 mol oxidized per min/mol of enzyme.
Tyrosine cross-linking has been established as the biological function of the DUOX enzymes in thyroid hormone biosynthesis for humans and in cuticle formation for C. elegans. Each domain was therefore assayed via fluorescence for dityrosine formation with tyrosine ethyl ester as a substrate (14) . Similar results were obtained with this more natural substrate; i.e. no activity with hDUOX1 and modest activity with CeDUOX1 1-589 ( Figure 5A ). To confirm any increase in fluorescence observed was due directly to the formation of dityrosine, HPLC analysis of the reactions was performed to isolate the dityrosine product ( Figure 5B) ; separation isolated the fluorescent product formed (t = 8 min) from unreacted tyrosine ethyl ester (t = 2.8 min). LC-MS identified the fluorescent product as dityrosine (m/z 417).
As an alternative to peroxidase activity, the DUOX1 domains may function as SODs, converting two molecules of superoxide to O 2 and H 2 O 2 . The hDUOX1 1-593 "peroxidase" domain, which appears unable to bind heme, could conceivably bind a metal ion necessary for SOD activity. To determine if any metal ions have copurified with hDUOX1 1-593 , the enzyme was submitted to metal analysis by inductively coupled argon plasma optical emission spectroscopy (ICP-OES, Garratt Callahan Analytical Laboratory). This analysis showed that the only proteinassociated metal ion was calcium, consistent with conservation of a calcium binding site among the classical peroxidases and the DUOX family (47). Calcium does not belong to the known set of metals utilized by SODs to support their function (the mammalian enzymes utilize copper, zinc, and/or manganese (48-51)); therefore, this result suggests hDUOX1 1-593 may also not function as a SOD. To further investigate, in the unlikely event calcium may be utilized for enzyme function, hDUOX1 and CeDUOX1 1-589 were evaluated for their ability to react with superoxide by a colorimetric inhibition assay utilizing WST-1 as a substrate (52, 53) . Authentic superoxide dismutase was assayed as a control over a profile of concentrations ( Figure 5C ). hDUOX1 and CeDUOX1 show less than 10% inhibition over concentrations from 10-120 ng/mL, over which SOD increases in inhibition strength to 70%. Superoxide dismutase demonstrates a high turnover rate even at low concentrations, which may not be shared by the DUOX enzymes. To ascertain if any activity may be obtained at higher concentrations, each enzyme was assayed under the same conditions at 1 µM concentration, both with and without the addition of 100 µM CaCl 2 . As shown in Figure 5D , even at this higher concentration, no significant dismutase activity is exhibited by the DUOX1 homologs, either in the presence or absence of additional calcium.
In sum, this collective activity data demonstrates hDUOX1 to be inactive as a peroxidase or superoxide dismutase, and CeDUOX1 1-589 to be inactive as a SOD, but exhibiting low level peroxidase activity. This low activity level is realistic for CeDUOX1 in vivo, and the DUOX family as a whole, to prevent cellular oxidative stress and to function in a controlled manner toward polymerization of tyrosines and/or generation of signaling molecules. In contrast, mammalian peroxidases require high peroxidase activity levels, herein demonstrated by the high level of ABTS turnover and tyrosine ethyl ester cross-linking observed with LPO. These levels are necessary for in vivo generation of antimicrobial agents, i.e. hypohalides, from bromide, chloride and thiocyanate oxidation.
Specifically, LPO has the characterized ability to rapidly oxidize bromide at acidic pH (24, 54) . Therefore, to support the theory that DUOX enzymes support controlled reactivity and should not oxidize halides, LPO was utilized as a control with both DUOX1 homologs to assay bromide oxidation. This study confirmed that neither DUOX "peroxidase" domain could oxidize bromide (LPO, (3.5 ± 0.7) x 10 3 mol oxidized per min/mol enzyme; CeDUOX1 1-589 and hDUOX1 , no significant oxidation). While a low activity level appears native to CeDUOX1 1-589 , the lack of an observed hDUOX1 function suggests that specific protein interactions may play a role in heme binding or in enhancing the activity of the protein.
DISCUSSION
The dual oxidase enzymes, the most recently discovered members of the NOX/DUOX family, have garnered much attention because of their unique N-terminal peroxidase-like domain(s). The focus on this region has so far been limited to cell suspension activity assays after expression in E. coli, and RNA interference experiments with C. elegans for determination of cellular localization and function (14) . Neither domain has been purified, leaving them largely uncharacterized. The inability to isolate this region from DUOX1 or DUOX2 for in vitro study leaves many questions regarding structure and function unanswered.
To better characterize these N-terminal regions we have first focused on the single dual oxidase isoform, DUOX1. Here we report that expression and purification of the human and C. elegans DUOX1 "peroxidase" domains (hDUOX1 and CeDUOX1 ) was achieved in a recombinant baculovirus system. These purified constructs demonstrate distinctly different interactions with the heme prosthetic group, in accord with the fact that a different number of critical active site residues is missing in the two DUOX domains ( Figure 1B) . Covalent heme association was found for CeDUOX1 , which lacks fewer of the critical residues, but heme was not found to stably bind in purified hDUOX1 .
In view of the absence of heme binding, it is not surprising that hDUOX1 has no peroxidase activity. This result is consistent with the in vivo finding that DUOX2, but not DUOX1, supports thyroid hormone biosynthesis. Mutations in the DUOX2 isoform have been conclusively shown to cause congenital hypothyroidism, a disorder that is not rescued by expression of DUOX1 in the thyroid (55) (56) (57) . Clear evidence has also demonstrated that DUOX2 provides functional heme-dependent peroxidase activity in human respiratory tract epithelium; interestingly, this study also showed that treatment of epithelial cells with cytokines (IL-4 and IL-13) enhanced DUOX1 expression, but did not induce measurable peroxidase activity (58) . Investigations of the DUOX2 N-terminal region are in progress to determine its interaction with heme and to define its catalytic activities.
Our biophysical data (circular dichroism and Trp fluorescence) suggest that hDUOX1 1-593 is folded properly, yet as isolated is inactive as either a peroxidase or a superoxide dismutase. Possible explanations for this include the absence of a protein-protein interaction required for heme binding/catalytic activity, expression/retention as a non-functional vestigial region, or a unique as yet to be identified domain functionality. DUOX1 is not the dominant isoform in the thyroid; instead, it is found at high levels in respiratory tract epithelial cells and has been proposed to provide ROS for airway homeostasis. Investigations of lung cancer cell lines identified the duox(s) as inactivated by hypermethylation, yet H 2 O 2 production was rescued by the introduction of DUOX1 and its maturation factor DUOXA1. This suggests that DUOX1 may be active in lung tissue, but requires other protein interactions for maturation (DUOXA1), transport, or activity (59, 60) . Recently, the DUOX maturation factors (DUOXA1 and DUOXA2) were shown to form stable cell surface complexes with the DUOX proteins, and may function as part of a H 2 O 2 generating enzyme complex (61) . Co-expression of hDUOX1 in the presence of DUOXA1, or pull-down assays of the "peroxidase" domain with mammalian cell lysates, may provide a better understanding of any specific protein interactions that modulate DUOX1 activity.
Consistent with the presence of a conserved heme binding residue (E238), CeDUOX1 has been found to covalently bind its prosthetic group. This interaction, combined with an ability to bind small ligands, suggests the CeDUOX1 1-589 hemebinding pocket has a similar profile to that of the classical mammalian peroxidases, despite the absence of some typical catalytic residues. Furthermore, the demonstration that protein covalent binding is increased upon exposure to H 2 O 2 , and is thus autocatalytic, links it tightly with both LPO and TPO, both of which share this behavior (29, 62) . Surprisingly, identification of a dihydroxyheme derivative upon enzymatic protein digestion of CeDUOX1 suggests that the protein may interact directly with the heme through 2 covalent bonds. This was unexpected based on sequence analysis of the heme binding residues, as the amino acid required for the second covalent heme bond in enzymes such as LPO is not present in DUOX1 ( Figure 1B) . It is plausible the hydroxylation may be the result of reaction with another residue (e.g., Y105); site specific mutagenesis studies will be required to confirm that a second covalent bond is actually present and to determine not only which residue is involved but also the nature of the bond.
Covalent heme binding itself demonstrates that CeDUOX1 1-589 has peroxidase activity, as autocatalytic binding is the result of a peroxidase reaction. However, when peroxidase activity is measured with two standard peroxidase substrates, ABTS and a tyrosine derivative, the peroxidase activity of CeDUOX1 1-589 is found to be much lower than that of LPO. This lower activity is consistent with the absence of a distal histidine residue that is critical for the high activity of most peroxidases (42) (43) (44) (45) (46) ). However, a low level of activity for the CeDUOX1 peroxidase domain may be desirable in the context of its function in the intact organism. CeDUOX1 is thought to function in polymerization of tyrosine residues in cuticle formation rather than in antibacterial defense. A low rate of peroxidase activity may be desirable in this role to prevent damage to the organism by an uncontrolled high level of peroxidase activity. It is instructive in this context that VPO1, another recently identified human peroxidase, has a much lower peroxidase activity than LPO despite the fact that it retains all the critical amino acid residues of a conventional peroxidase (54) .
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Fayadat, L., Niccoli-Sire, P., Lanet, J., and Franc, J. . Each DUOX1 protein contains an N-terminal extracellular "peroxidase" domain (dark gray rectangle), putative TM domains (light gray tubes), and cytosolic EF-hand and NADPH oxidase domains (light grey rectangles). Both proteins were truncated to generate soluble expression constructions focusing on the "peroxidase" domain, as shown. (B) Sequence alignment of classical peroxidase domains with the DUOX1 proteins. Highlighted segments shown focus on regions of active site residues (bold face) including the distal histidine (hMPO H261), catalytic arginine (hMPO R405), proximal histidine (hMPO H502), and covalent heme binding residues (hMPO D260, E408). hMPO, human myeloperoxidase; hEPO, human eosinophil peroxidase; bLPO, bovine lactoperoxidase; hTPO, human thyroid peroxidase; hVPO, human vascular peroxidase; hPxn, human peroxidasin. Figure 1 by guest on October 30, 2017 
